| DIRECT COMPETITOR COMPARISON | |
| NVS | JNJ | MRK | PFE | Industry | | Market Cap: | 127.80B | 174.95B | 77.75B | 150.70B | 128.60M | | Employees: | 99,000 | 118,700 | 55,200 | 81,800 | 181 | | Qtrly Rev Growth (yoy): | 2.40% | -5.30% | 1.80% | -2.90% | 14.60% | | Revenue (ttm): | 42.31B | 60.53B | 23.37B | 45.82B | 31.21M | | Gross Margin (ttm): | 72.61% | 71.08% | 76.36% | 86.61% | 72.61% | | EBITDA (ttm): | 11.24B | 19.05B | 7.81B | 21.31B | -1.65M | | Oper Margins (ttm): | 21.50% | 26.94% | 26.63% | 37.42% | 2.37% | | Net Income (ttm): | 7.59B | 12.77B | 8.05B | 8.09B | N/A | | EPS (ttm): | 3.34 | 4.579 | 3.808 | 1.204 | N/A | | P/E (ttm): | 16.85 | 13.85 | 9.68 | 15.51 | 13.73 | | PEG (5 yr expected): | 2.89 | 1.85 | 2.18 | 5.85 | 2.18 | | P/S (ttm): | 2.98 | 2.86 | 3.27 | 3.20 | 3.28 |
|
| JNJ = Johnson & Johnson | | MRK = Merck & Co. Inc. | | PFE = Pfizer Inc. | | Industry = Drug Manufacturers - Major | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.7405 | 0.69% | 57.43B | 12.38 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.64 | 1.49% | 13.78B | 15.94 | | Genzyme Corp. | GENZ | 51.31 | 1.20% | 13.62B | 29.25 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.15 | 0.09% | 41.53B | 17.85 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.915 | 2.28% | 9.08B | 1039.08 | | Teva Pharmaceutical Industries Limited | TEVA | 53.30 | 0.97% | 46.96B | 48.76 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.50 | 1.11% | 3.98B | 19.33 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.87 | 0.34% | 2.95B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.17 | 1.68% | 5.55B | 111.47 | | Pfizer Inc. | PFE | 18.675 | 2.78% | 150.70B | 15.51 | | Johnson & Johnson | JNJ | 63.41 | 0.91% | 174.95B | 13.85 | | GlaxoSmithKline plc | GSK | 42.45 | 2.36% | 107.61B | 13.48 | | Sanofi-Aventis | SNY | 39.3382 | 3.63% | 102.72B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 56.2677 | 1.20% | 127.80B | 16.85 | | RHHBY.PK | 41.45 | 1.30% | N/A | N/A | | AstraZeneca plc | AZN | 45.67 | 1.87% | 66.22B | 9.17 | | Abbott Laboratories | ABT | 54.50 | 0.02% | 84.30B | 14.77 | | Bristol-Myers Squibb Co. | BMY | 24.78 | -2.09% | 49.09B | 12.82 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|